| human | Q5 |
| P735 | given name | Louis | Q2897866 |
| Louis | Q2897866 | ||
| P106 | occupation | researcher | Q1650915 |
| Q43088272 | 6-mercaptopurine inhibits atherosclerosis in apolipoprotein e*3-leiden transgenic mice through atheroprotective actions on monocytes and macrophages |
| Q44011006 | A low-fat diet has a higher potential than energy restriction to improve high-fat diet-induced insulin resistance in mice |
| Q35094217 | A novel EPO receptor agonist improves glucose tolerance via glucose uptake in skeletal muscle in a mouse model of diabetes |
| Q34608233 | Acute central neuropeptide Y administration increases food intake but does not affect hepatic very low-density lipoprotein (VLDL) production in mice |
| Q46427847 | Acute hepatic steatosis in mice by blocking beta-oxidation does not reduce insulin sensitivity of very-low-density lipoprotein production |
| Q45270099 | Acute inhibition of hepatic beta-oxidation in APOE*3Leiden mice does not affect hepatic VLDL secretion or insulin sensitivity |
| Q60531985 | An Extrahepatic Receptor-associated Protein-sensitive Mechanism Is Involved in the Metabolism of Triglyceride-rich Lipoproteins |
| Q34858025 | Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin |
| Q46902689 | Anti-atherosclerotic effect of amlodipine, alone and in combination with atorvastatin, in APOE*3-Leiden/hCRP transgenic mice |
| Q60233040 | Apo E Polymorphism in Relation to the Expression of Familial Dysbetalipoproteinemia |
| Q47748338 | ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis |
| Q46466019 | ApoC-III deficiency prevents hyperlipidemia induced by apoE overexpression |
| Q33242076 | ApoE plasma levels and risk of cardiovascular mortality in old age |
| Q36558367 | ApoE2-associated hypertriglyceridemia is ameliorated by increased levels of apoA-V but unaffected by apoC-III deficiency |
| Q51014728 | Apolipoprotein A5 deficiency aggravates high-fat diet-induced obesity due to impaired central regulation of food intake. |
| Q24299172 | Apolipoprotein C-I binds free fatty acids and reduces their intracellular esterification |
| Q45285342 | Apolipoprotein C3 deficiency results in diet-induced obesity and aggravated insulin resistance in mice |
| Q24312753 | Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo |
| Q41825540 | Apolipoprotein CI overexpression is not a relevant strategy to block cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice |
| Q60233038 | Apolipoprotein E Polymorphisms and the Genetic Heterogeneity of Familial Dysbetalipoproteinemia |
| Q41066976 | Apolipoprotein E as a risk factor for coronary heart disease: a genetic and molecular biology approach. |
| Q56451020 | Apolipoprotein gene cluster on chromosome 19 |
| Q36159060 | Apolipoproteins modulate the inflammatory response to lipopolysaccharide |
| Q33976115 | Aspirin reduces hypertriglyceridemia by lowering VLDL-triglyceride production in mice fed a high-fat diet |
| Q46160760 | Bexarotene induces dyslipidemia by increased very low-density lipoprotein production and cholesteryl ester transfer protein-mediated reduction of high-density lipoprotein |
| Q34744777 | Both transient and continuous corticosterone excess inhibit atherosclerotic plaque formation in APOE*3-leiden.CETP mice |
| Q42097167 | Brown adipose tissue takes up plasma triglycerides mostly after lipolysis |
| Q46411188 | Brown adipose tissue volume in healthy lean south Asian adults compared with white Caucasians: a prospective, case-controlled observational study |
| Q44552197 | CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice |
| Q42435953 | CD36 is important for adipocyte recruitment and affects lipolysis |
| Q37463344 | CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice |
| Q35107299 | CETP expression reverses the reconstituted HDL-induced increase in VLDL. |
| Q45810167 | CNTO736, a novel glucagon-like peptide-1 receptor agonist, ameliorates insulin resistance and inhibits very low-density lipoprotein production in high-fat-fed mice |
| Q41585297 | Caspase-1 deficiency in mice reduces intestinal triglyceride absorption and hepatic triglyceride secretion |
| Q60233042 | Characterisation and Mode of Inheritance of Apolipoprotein E3-Leiden |
| Q40237321 | Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice |
| Q35152229 | Circulating insulin stimulates fatty acid retention in white adipose tissue via KATP channel activation in the central nervous system only in insulin-sensitive mice |
| Q39741648 | Colestilan decreases weight gain by enhanced NEFA incorporation in biliary lipids and fecal lipid excretion |
| Q48218638 | Detrimental effects of constant light exposure and high-fat diet on circadian energy metabolism and insulin sensitivity |
| Q46873973 | Development of atopic dermatitis in mice transgenic for human apolipoprotein C1. |
| Q55042300 | Dietary sphingolipids lower plasma cholesterol and triacylglycerol and prevent liver steatosis in APOE*3Leiden mice. |
| Q44491764 | Differential effects of amlodipine and atorvastatin treatment and their combination on atherosclerosis in ApoE*3-Leiden transgenic mice |
| Q38325289 | Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice |
| Q37377010 | Effect of plasma triglyceride metabolism on lipid storage in adipose tissue: studies using genetically engineered mouse models |
| Q44353368 | Effects of amlodipine, atorvastatin and combination of both on advanced atherosclerotic plaque in APOE*3-Leiden transgenic mice |
| Q46990753 | Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL. |
| Q51497885 | Endogenous interleukin-10 protects against hepatic steatosis but does not improve insulin sensitivity during high-fat feeding in mice. |
| Q34764818 | Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology |
| Q28730126 | Estimation of activity related energy expenditure and resting metabolic rate in freely moving mice from indirect calorimetry data |
| Q51544919 | Expression of type III hyperlipoproteinemia in apolipoprotein E2 (Arg158 --> Cys) homozygotes is associated with hyperinsulinemia. |
| Q42175229 | Fenofibrate increases very low density lipoprotein triglyceride production despite reducing plasma triglyceride levels in APOE*3-Leiden.CETP mice |
| Q34469947 | GLP-1 receptor activation inhibits VLDL production and reverses hepatic steatosis by decreasing hepatic lipogenesis in high-fat-fed APOE*3-Leiden mice |
| Q45171385 | Generation of a recombinant apolipoprotein E variant with improved biological functions: hydrophobic residues (LEU-261, TRP-264, PHE-265, LEU-268, VAL-269) of apoE can account for the apoE-induced hypertriglyceridemia |
| Q38519853 | Genomic analysis of the response of mouse models to high-fat feeding shows a major role of nuclear receptors in the simultaneous regulation of lipid and inflammatory genes |
| Q37187316 | Gut-brain axis |
| Q43990754 | HOE 402 lowers serum cholesterol levels by reducing VLDL-lipid production, and not by induction of the LDL receptor, and reduces atherosclerosis in wild-type and LDL receptor-deficient mice |
| Q44739061 | Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol |
| Q34776315 | Hepatocyte-specific IKK-β activation enhances VLDL-triglyceride production in APOE*3-Leiden mice |
| Q33898304 | Hepatocyte-specific IKKβ expression aggravates atherosclerosis development in APOE*3-Leiden mice |
| Q33780322 | High levels of dietary stearate promote adiposity and deteriorate hepatic insulin sensitivity |
| Q55162930 | High levels of whole-body energy expenditure are associated with a lower coupling of skeletal muscle mitochondria in C57Bl/6 mice |
| Q55162921 | High-fat diets rich in medium- versus long-chain fatty acids induce distinct patterns of tissue specific insulin resistance |
| Q46061850 | Human CETP aggravates atherosclerosis by increasing VLDL-cholesterol rather than by decreasing HDL-cholesterol in APOE*3-Leiden mice |
| Q37430584 | Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size |
| Q44514596 | Increased hepatic insulin sensitivity together with decreased hepatic triglyceride stores in hormone-sensitive lipase-deficient mice |
| Q43974040 | Induction of atherosclerotic plaque rupture in apolipoprotein E-/- mice after adenovirus-mediated transfer of p53. |
| Q34238637 | Inhibition of the central melanocortin system decreases brown adipose tissue activity |
| Q38342071 | Integrative biological analysis of the APOE*3-leiden transgenic mouse |
| Q38091828 | Interactions between inflammation and lipid metabolism: relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis |
| Q41777277 | Intracerebroventricular administration of neuropeptide Y induces hepatic insulin resistance via sympathetic innervation |
| Q45077923 | Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin |
| Q40189953 | Intrauterine exposure to maternal atherosclerotic risk factors increases the susceptibility to atherosclerosis in adult life |
| Q40089428 | LDL receptor deficiency results in decreased cell proliferation and presynaptic bouton density in the murine hippocampus |
| Q28732458 | Lipidomics reveals multiple pathway effects of a multi-components preparation on lipid biochemistry in ApoE*3Leiden.CETP mice |
| Q46941597 | Local Cre-mediated gene recombination in vascular smooth muscle cells in mice |
| Q46425298 | Local perivascular delivery of anti-restenotic agents from a drug-eluting poly(epsilon-caprolactone) stent cuff |
| Q47320273 | Low-density lipoprotein receptor-knockout mice display impaired spatial memory associated with a decreased synaptic density in the hippocampus |
| Q44816416 | META060 protects against diet-induced obesity and insulin resistance in a high-fat-diet fed mouse |
| Q45927694 | Macrophage p53 controls macrophage death in atherosclerotic lesions of apolipoprotein E deficient mice. |
| Q24300872 | Macrophage-specific inhibition of NF-kappaB activation reduces foam-cell formation |
| Q37209360 | Maternal transmission of risk for atherosclerosis |
| Q36149802 | Metabolomics in the context of systems biology: bridging traditional Chinese medicine and molecular pharmacology |
| Q44553256 | Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype |
| Q46913208 | Olmesartan and pravastatin additively reduce development of atherosclerosis in APOE*3Leiden transgenic mice |
| Q44605262 | Overexpression of APOC1 in obob mice leads to hepatic steatosis and severe hepatic insulin resistance |
| Q46923076 | Oxyntomodulin ameliorates glucose intolerance in mice fed a high-fat diet |
| Q46159072 | PXR agonism decreases plasma HDL levels in ApoE3-Leiden.CETP mice |
| Q44995518 | PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet |
| Q42731618 | Perfluoroalkyl sulfonates cause alkyl chain length-dependent hepatic steatosis and hypolipidemia mainly by impairing lipoprotein production in APOE*3-Leiden CETP mice |
| Q42797513 | Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity |
| Q53871573 | Phenotype characterisation using integrated gene transcript, protein and metabolite profiling. |
| Q27344569 | Plasma and liver lipidomics response to an intervention of rimonabant in ApoE*3Leiden.CETP transgenic mice |
| Q46783798 | Plasma apolipoprotein CI correlates with increased survival in patients with severe sepsis |
| Q52931087 | Plasma cholesteryl ester transfer protein is predominantly derived from Kupffer cells. |
| Q33597037 | Prenatal exposure to apoE deficiency and postnatal hypercholesterolemia are associated with altered cell-specific lysine methyltransferase and histone methylation patterns in the vasculature |
| Q36800299 | Preoperative apolipoprotein CI levels correlate positively with the proinflammatory response in patients experiencing endotoxemia following elective cardiac surgery |
| Q44064884 | Raman spectroscopic investigation of atorvastatin, amlodipine, and both on atherosclerotic plaque development in APOE*3 Leiden transgenic mice |
| Q60233035 | Rare mutations in the APOE gene associated with dominant mode of inheritance of Familial Dysbetalipoproteinemia (FD) |
| Q30984423 | Response of apolipoprotein E*3-Leiden transgenic mice to dietary fatty acids: combining liver proteomics with physiological data |
| Q46790589 | Ritonavir impairs lipoprotein lipase-mediated lipolysis and decreases uptake of fatty acids in adipose tissue |
| Q43199097 | Ritonavir protects against the development of atherosclerosis in APOE*3-Leiden mice |
| Q44536746 | Rosiglitazone improves muscle insulin sensitivity, irrespective of increased triglyceride content, in ob/ob mice |
| Q44562028 | Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin |
| Q45197821 | Rosuvastatin reduces plasma lipids by inhibiting VLDL production and enhancing hepatobiliary lipid excretion in ApoE*3-leiden mice |
| Q39739995 | Selective parasympathetic innervation of subcutaneous and intra-abdominal fat--functional implications |
| Q24319030 | Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL |
| Q45171650 | Sixteen hours of fasting differentially affects hepatic and muscle insulin sensitivity in mice |
| Q38315060 | Specific and efficient targeting of adenovirus vectors to macrophages: application of a fusion protein between an adenovirus-binding fragment and avidin, linked to a biotinylated oligonucleotide |
| Q40720835 | Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles |
| Q35561118 | Stimulatory effect of insulin on glucose uptake by muscle involves the central nervous system in insulin-sensitive mice |
| Q37457206 | Sympathetic nervous system control of triglyceride metabolism: novel concepts derived from recent studies |
| Q47598134 | The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis |
| Q35058473 | The effect of PPE-induced emphysema and chronic LPS-induced pulmonary inflammation on atherosclerosis development in APOE*3-LEIDEN mice |
| Q48497463 | The effects of high fat diet on the basal activity of the hypothalamus-pituitary-adrenal axis in mice |
| Q34326186 | The expression of type III hyperlipoproteinemia: involvement of lipolysis genes |
| Q30341682 | The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism? |
| Q47926062 | The transport of triglycerides through the secretory pathway of hepatocytes is impaired in apolipoprotein E deficient mice |
| Q46610879 | Torcetrapib does not reduce atherosclerosis beyond atorvastatin and induces more proinflammatory lesions than atorvastatin |
| Q46384631 | Triglyceride-rich lipoprotein metabolism in unique VLDL receptor, LDL receptor, and LRP triple-deficient mice |
| Q46828709 | Tumor necrosis factor-alpha plays an important role in restenosis development |
| Q46380680 | Tumor necrosis factor-alpha promotes atherosclerotic lesion progression in APOE*3-Leiden transgenic mice |
| Q43955468 | VLDL receptor deficiency enhances intimal thickening after vascular injury but does not affect atherosclerotic lesion area |
| Q47405241 | Well-characterized garlic-derived materials are not hypolipidemic in APOE*3-Leiden transgenic mice |
| Q34612131 | Znf202 affects high density lipoprotein cholesterol levels and promotes hepatosteatosis in hyperlipidemic mice |
Search more.